Vitrolife AB (publ) (VTRLY)

Market Cap	1.93B
Revenue (ttm)	359.64M
Net Income (ttm)	49.61M
Shares Out	n/a
EPS (ttm)	0.37
PE Ratio	38.84
Forward PE	32.76
Dividend	0.07 (0.46%)
Ex-Dividend Date	May 2, 2025

Volume	100
Average Volume	13
Open	14.90
Previous Close	14.62
Day's Range	14.90 - 14.90
52-Week Range	13.30 - 25.00
Beta	1.80
RSI	21.79
Earnings Date	Jul 17, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: OTCMKTS
• Ticker Symbol: VTRLY

Financial Performance

Financial numbers in SEK